Can PLI, China Plus One keep India’s pharma sector in pink of health?
Business

Can PLI, China Plus One keep India’s pharma sector in pink of health?

By Dan Neff

The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply.

Synopsis

The Indian pharmaceutical market flattened after the pandemic led to a massive upsurge in demand for drugs. The industry saw a rise in sales during the Covid spike but that settled down as the number of coronavirus cases came down, except for Q1FY2022, where the second Covid wave was dominant. This resulted in a dip in the top line of pharma companies in the successive quarters.

The Covid lockdown and supply chain disruptions have led to extreme volatility in the prices of active pharmaceutical ingredients (APIs). This is bad news for Indian pharma companies as most of them import APIs from China. The sector is poised to grow now, backed by government initiatives to reduce import reliance on APIs. How will these impact business and valuation of the pharma companies?The Indian pharmaceutical market flattened after the

BY

Gaurav Jain & Parimal Ade

ET CONTRIBUTORS

  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

For all the latest Business News Click Here 

 For the latest news and updates, follow us on Google News. 

Read original article here

Denial of responsibility! TheDailyCheck is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.

Dan Neff